Episode Details

#BPC157 #PeptideTherapy #TendonHealing #RegenerativeMedicine #healthscience 

BPC-157 is everywhere right now — but does the evidence actually justify putting this peptide into your body? In this video, Dr. Mohammed Paika (board-certified internal medicine & obesity medicine) breaks down what BPC-157 actually does, what the animal research shows, what we really know about human safety, and the one theoretical risk that concerns him most as a physician.

BPC-157 is not FDA-approved for any human use.

🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime Access
Comprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.
https://www.drmohammedpaika.com

📩 FREE GLP-1 Diet Cookbook + Weekly Newsletter
Get weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.
https://www.drmohammedpaika.com/newsletter

📚 The Weight Equation & The Physician’s Physique
https://www.drmohammedpaika.com/books

👥 Metabolic Health Community
https://www.skool.com/metabolic-health-community-5316

Timestamps

0:00 – Intro: Does the evidence justify this?
0:44 – What BPC-157 Actually Is
2:19 – How BPC-157 Works (The Mechanism)
4:18 – The Musculoskeletal Evidence
7:51 – Gut Health
10:58 – Brain & Nervous System
13:14 – Cardiovascular Health
14:07 – The Honest Safety Picture
16:20 – What Human Data We Actually Have
19:24 – The Risk That Concerns Me Most (Cancer)
21:46 – Who Should Actually Consider This
24:26 – The Regulatory Reality (FDA, 2026)

References
Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. J Orthop Res. 2003;21(6):976-983.
Krivic A, et al. Achilles detachment in rat and BPC 157: tendon-to-bone healing. J Orthop Res. 2006;24(5):982-989.
Cerovecki T, et al. Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-1161.
Staresinic M, et al. Effective therapy of transected quadriceps muscle in rat: BPC 157. J Orthop Res. 2006;24(5):1109-1117.
Novinscak T, et al. BPC 157 as effective therapy for muscle crush injury in the rat. Surg Today. 2008;38(8):716-725.
Šebečić B, et al. Osteogenic effect of BPC-157 on segmental bone defect healing in rabbits. Bone. 1999;24(3):195-202.
Duzel A, et al. BPC 157 in colitis and ischemia/reperfusion in rats. World J Gastroenterol. 2017;23(48):8465-8488.
Vuksic T, et al. BPC 157 heals ileoileal anastomosis in the rat. Surg Today. 2007;37(9):768-777.
Sikiric P, et al. BPC 157 effects on stomach mucosa integrity and blood pressure. Life Sci. 1994;54(5):PL63-68.
Park JM, et al. BPC 157 rescued NSAID-cytotoxicity via intestinal permeability. Curr Pharm Des. 2020;26(25):2971-2981.
Tudor M, et al. Traumatic brain injury in mice and BPC 157 effect. Regul Pept. 2010;160(1-3):26-32.
Vukojević J, et al. BPC 157 in hippocampal ischemia/reperfusion injuries in rats. Brain Behav. 2020;10(8):e01726.
Gjurasin M, et al. Peptide therapy with BPC 157 in traumatic nerve injury. Regul Pept. 2010;160(1-3):33-41.
Perovic D, et al. BPC 157 improves healing course of spinal cord injury in rats. J Orthop Surg Res. 2019;14:199.
Zemba Cilic A, et al. BPC 157 counteracts catalepsy in rat schizophrenia-like models. Behav Brain Res. 2021;396:112919.
Sikiric P, et al. Antidepressant effect of BPC 157 in Porsolt's test and chronic stress in rats. J Physiol Paris. 2000;94(2):99-104.
Xu C, et al. Preclinical safety evaluation of BPC-157. Regul Toxicol Pharmacol. 2020;114:104665.
He W, et al. Pharmacokinetics of BPC-157 in rats and dogs. Front Pharmacol. 2022;13:1026182.
Lee E, et al. Effect of BPC-157 on interstitial cystitis symptoms: a pilot study. Altern Ther Health Med. 2024;30